[HTML][HTML] DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy
R Huang, PK Zhou - Signal transduction and targeted therapy, 2021 - nature.com
Genomic instability is the hallmark of various cancers with the increasing accumulation of
DNA damage. The application of radiotherapy and chemotherapy in cancer treatment is …
DNA damage. The application of radiotherapy and chemotherapy in cancer treatment is …
A Microenvironment Dual‐Responsive Nano‐Drug Equipped with PD‐L1 Blocking Peptide Triggers Immunogenic Pyroptosis for Prostate Cancer Self‐Synergistic …
H Wang, Z Gao, D Jiao, Y Zhang… - Advanced Functional …, 2023 - Wiley Online Library
Induction of immunogenic cell death (ICD) in tumor combined with immune checkpoint
blockade (ICB) therapy is widely developed to improve the efficacy of cancer …
blockade (ICB) therapy is widely developed to improve the efficacy of cancer …
[HTML][HTML] FAPI PET/CT in the diagnosis of abdominal and pelvic tumors
T Yang, L Ma, H Hou, F Gao, W Tao - Frontiers in Oncology, 2022 - frontiersin.org
Positron emission tomography/computed tomography (PET/CT) with 18F-
fluorodeoxyglucose (18F-FDG) is currently a standard imaging examination used in clinical …
fluorodeoxyglucose (18F-FDG) is currently a standard imaging examination used in clinical …
Cuproptosis regulates microenvironment and affects prognosis in prostate cancer
C Li, Y Xiao, H Cao, Y Chen, S Li, F Yin - Biological Trace Element …, 2024 - Springer
Current immunotherapy for prostate cancer is still in the stage of clinical trials. This delay is
thought to be caused by an unclear regulatory mechanism of the immune microenvironment …
thought to be caused by an unclear regulatory mechanism of the immune microenvironment …
S100A14 inhibits cell growth and epithelial–mesenchymal transition (EMT) in prostate cancer through FAT1-mediated Hippo signaling pathway
S Jiang, Y Zhu, Z Chen, Z Huang, B Liu, Y Xu, Z Li… - Human Cell, 2021 - Springer
Prostate cancer (PCA) is an epithelial malignant tumor occurring in the prostate gland. It is
the second most common male cancer in the world and one of the top five cancer deaths in …
the second most common male cancer in the world and one of the top five cancer deaths in …
Genetics of prostate carcinoma
The aim of this review is to provide a brief overview of some current approaches regarding
diagnostics, pathologic features, treatment, and genetics of prostate carcinoma (PCa) …
diagnostics, pathologic features, treatment, and genetics of prostate carcinoma (PCa) …
[HTML][HTML] Integrated analysis of the transcriptome profile reveals the potential roles played by long noncoding RNAs in immunotherapy for sarcoma
B Pang, Y Hao - Frontiers in oncology, 2021 - frontiersin.org
Background Long-term survival is still low for high-risk patients with soft tissue sarcoma
treated with standard management options, including surgery, radiation, and chemotherapy …
treated with standard management options, including surgery, radiation, and chemotherapy …
[HTML][HTML] Diagnostic value of integrated 18F-PSMA-1007 PET/MRI compared with that of biparametric MRI for the detection of prostate cancer
Y Zeng, X Leng, H Liao, G Jiang, P Chen - Prostate International, 2022 - Elsevier
Objective To assess the diagnostic value of fluorine 18 (18 F)-labeled prostate-specific
membrane antigen (PSMA)-1007 Positron emission tomography/Magnetic resonance …
membrane antigen (PSMA)-1007 Positron emission tomography/Magnetic resonance …
[HTML][HTML] Current update on prostate cancer immunotherapy
JE Kim, K Lee, IY Kim - Journal of Urologic Oncology, 2023 - e-juo.org
Immunotherapy encompasses a wide array of treatment modalities that utilize our natural
defense system to fight against cancer and in recent years has contributed to significant …
defense system to fight against cancer and in recent years has contributed to significant …
[HTML][HTML] Elective checkpoint inhibitor discontinuation in metastatic solid tumor patients: A case series
R Lopez-Flores, W Samlowski, L Perez - Annals of case reports, 2022 - ncbi.nlm.nih.gov
Methods: A retrospective analysis was performed in adults with metastatic solid tumors
treated with CKI-based therapy. Patients with solid tumors who achieved complete remission …
treated with CKI-based therapy. Patients with solid tumors who achieved complete remission …